Baldur’s Gate 3 is populated by a great many NPCs. Some are friends, some are foes, and some are of uncertain allegiance. One character you’ll encounter is Araj Oblodra, who expresses an interest in taking your blood. But is it a wise idea to let her? If you’re wondering whether you should let Araj Oblodra take your blood in Baldur’s Gate 3, here’s the answer. The Advantages and Disadvantages of Letting Araj Oblodra Take Your Blood in BG3 Araj Oblodra is an NPC you meet in Moonrise Towers and is probably a Drow. Why probably? Because there’s something a little off about her, and she could be something else entirely. Killing her doesn’t reveal anything, but even if she’s not technically undead, she’s not your run-of-the-mill dark elf. Should that make you suspicious? Absolutely. But the good news is there’s no disadvantage from giving her your character’s blood. And the advantage is that you’ll get a potion, an Elixir, in return. Each of these has unique effects depending on the race that donated. How to Give Her Your Blood Donating blood is pretty simple. Just go up to her and she’ll talk about wanting your blood. Follow that conversation and say yes to giving her your blood. She’ll give you an Elixir in return. You can only do that once, as she’ll turn you down if you try again. But if you switch to another character and speak to her you’ll, again, be able to trade blood for another Elixir. It’s worth doing this for each member of your party, even characters at your camp you’ve never used. Just fast travel to your camp, get them to join you, and have them donate. Even though the Elixirs come from a specific race’s blood, eg Elixir of Tiefling Vice, they can be used by any character. Should You Force Astarion to Drink Araj Oblodra’s Blood in BG3 Araj will, after you’ve donated blood for the first time, offer you another deal. If Astarion drinks her blood, she’ll give you a powerful potion, one that has a permanent effect. The potion, as you later discover if you go ahead with the deal, raises the drinker’s strength by two. This is a permanent change. Elixirs last until you have a long rest, but the potion you get for this deal lasts forever and can be drunk by anyone. What’s the catch? Simply that Astarion doesn’t want to drink her blood, and you’ll have to talk him into it. There’s no persuasion roll involved. You can just tell him to do it and he will. But if you do force him to drink her blood, you’ll get disapproval points from Astarion. Conversely, if you tell him you respect his choice, you get approval points. So really, it’s up to you. Are you willing to lose some of Astarion’s respect in return for two extra strength points? There are no other negative effects. Astarion remarks that her blood tastes disgusting, fetid, and corrupted, but it doesn’t damage him physically. There’s also a little extra dialogue later, but it won’t absolutely ruin whatever relationship the two of you have. Araj’s initial demeanor suggests being bitten has always been a fantasy, but that may be a smokescreen. She briefly talks about using the bite to brew something up, making use of whatever Astarion’s bite introduced into her veins. But I haven’t yet seen if Baldur’s Gate 3 address that. So, there are no major drawbacks to letting Araj Oblodra take your blood in Baldur’s Gate 3, but going further will incur Astarion’s disapproval. If you have other questions about the game, make sure to look through our full set of guides for more answers.
Category: Blood
LINCOLN, Neb. (KOLN) – It was an intense showing of support, and a somber time that hangs over Lincoln in the history books: August 26th, 2020. That was the day Investigator Mario Herrera was shot in the line of duty during a standoff near 33rd & Holdrege. In the days that followed, 12 specifically, Herrera fought for his life with the help of many blood transfusions that were only possible because of donors at blood centers across eastern Nebraska. Today, and until Sept. 7th, Lincoln Police, Lincoln Fire & Rescue, and the Nebraska Community Blood Bank are working to make sure those 12 days in 2020 are not remembered just as a somber occurrence. The 12 Days of Hope Blood Drive is being held to not only honor Herrera’s life, but also to continue to keep at the forefront the critical need for blood donations to help others who need it. “Band Together to Save Lives” the motto says. That’s what happened in 2020, and that’s what all three agencies are hoping Lincolnites will do over the course of the remaining time of the event. On Monday, August 28th, LFR and LPD’s Southeast team will be holding a blood donation drive at the Joint Public Safety Center at 66th & Pine Lake, as NCBB’s Bloodmobile will be at the station for donors to stop by to help save a life from 9 a.m. to 2 p.m. You’re encouraged to stop by, schedule an appointment, or stop by LPD’s headquarters at 9th and K on September 7th, when the Bloodmobile will return for another round of taking donations. You can schedule an appointment by clicking this link or this link. You can also do so by visiting the NCBB’s website. Copyright 2023 KOLN. All rights reserved.
In a recent study published in the Med Journal, researchers trained machine learning (ML) models to analyze RNA molecular signatures in patients’ blood and evaluated their performance in distinguishing between common infectious pediatric diseases. Their results elucidate that ML models assessing differential gene expression levels can rapidly differentiate between 18 inflammatory and infectious diseases in children. Notable, these models’ diagnostic accuracy was comparable to medical health professionals perusing conventional clinical data. Given the poor diagnostic accuracy and severe delays of current diagnostic approaches, this proof of concept shows excellent promise in diagnosing illnesses during pediatric care in the future. Study: Diagnosis of childhood febrile illness using a multi-class blood RNA molecular signature. Image Credit: NDABCreativity/Shutterstock.com The limitations of today’s pediatric diagnoses Children seeking medical care most commonly suffer from inflammatory and infectious diseases in hospital and community settings. Of these, only a small portion of children are infected with severe bacterial or inflammatory conditions, presenting clinical teams with the conundrum of appropriately identifying and treating this cohort without over-treating most patients suffering from self-limiting viral infections. “Conventional diagnostic tests cannot distinguish the multitude of potential etiologies with sufficient speed and accuracy to inform initial treatment. Culture-based microbiological diagnosis is slow, and while molecular diagnostic techniques are faster, they are limited by the pathogens included in the panel and positive results may identify pathogens that are not the cause of the current illness, particularly for respiratory samples.” Conventional viral pathogen detection often identifies a single viral pathogen but fails to capture infections of multiple interacting microbes, limiting their diagnostic application. Most severe infections are localized in hard-to-access sites (especially the lungs), resulting in false negative reports despite severe clinical infection symptoms. Inflammatory conditions, including Kawasaki disease (KD) and juvenile idiopathic arthritis, do not currently have tests to confirm or refute diagnosis, resulting in severe delays in treatment initiation, or worse, disease misidentification. Alarmingly, less than half of children admitted with a fever or even to a pediatric intensive care unit ultimately receive a definitive diagnostic verdict. This forces healthcare professionals to rely on interventions involving broad-spectrum antibiotics for even the most harmless infections, thereby contributing to the growing problem of antimicrobial drug resistance. Recently, RNA sequencing (RNA-seq) has been explored as an alternative diagnostic approach, not limited by waiting times associated with conventional diagnostic procedures. A growing body of research elucidates that transcriptional signatures in whole-blood samples can rapidly and accurately distinguish between bacterial and viral infections, dengue, malaria, rotavirus, respiratory syncytial virus, tuberculosis (TB), and inflammatory conditions, including systemic lupus erythematosus (SLE) and KD. A noteworthy limitation of these studies is that they focus on simplified binary distinctions – one-versus-one (bacterial or viral infection) or one-versus-all (TB or any other disease) – thereby reducing their practical clinical applications. About the study The present study employs a least absolute shrinkage and selection operator (LASSO) and Ridge regression hybrid-derived feature selection and classification approach to alleviate the limitations of previous research undertaken in the field. Researchers trained ML classifiers on 12 gene expression microarray datasets and subsequently tested model performance on an independent patient cohort whose whole-blood RNA-seq data was acquired. To discover the biomarker panel used for model training, 12 publicly available microarray datasets of children (n = 1,212) with acute febrile illness and healthy controls were used. Related Stories Control data was used to batch correct results using the COmbat CO-Normalization Using conTrols (COCONUT) method. Patients for whom clinical validation of illness was available were included in the study, while those with multiple potential causative pathogens were excluded. This resulted in a final dataset of 338 bacterial, 290 viral, and 487 inflammatory cases. Malaria was the only identified parasitic pathogen in the dataset (n = 97). This dataset was randomly divided into training (75%) and test (25%) data using a stratified holdout approach to maintain class proportions. Five ML models were trained and assessed, of which the LASSO + Ridge hybrid model was identified as the best-fit model that allowed cost-sensitivity evaluation. Cost-sensitivity (also called ‘cost-sensitive learning’) is a model penalization algorithm that uses the consensus judgment of multiple field experts to assign ‘weightage’ to the demerits of disease misidentification or treatment initiation delays. This allowed for the prioritization of predictions in favor of conditions for which misdiagnosis consequences are highest. While the above approach is helpful for specific disease identification and long-term clinical intervention, most pediatric cases, especially severe infections, require immediate treatment of the broad group of causative agents (bacterial, viral, or inflammatory). All data was categorized into viral, bacterial, or inflammatory to address this need and reanalyzed. Since TB and KD differ significantly from other bacterial and inflammatory conditions, respectively, in their pathology, management, and transcript signatures, they were treated as independent classes. “These predictions allow the model to reflect the diagnostic classification used in clinical decision making and simultaneously address multiple clinical questions. The clinical teams can be provided with the probabilities for each patient to belong in each class as an optimal input for decision making.” The final ML model was cross-validated on an independent dataset comprising whole-blood RNA-seq data from 411 patients covering all broad diagnostic classes and 18 under-study diseases to validate the LASSO-Ridge hybrid model performance. Finally, ML models were benchmarked against previous one-versus-all studies using linear model coefficients, receiver operating characteristic (ROC), and area under the curve (AUC) measures. Study findings The LASSO-Ridge ML model identified 161 RNA probes comprising 155 genes capable of distinguishing between 18 possible pediatric conditions. Since 10 genes were underrepresented across the datasets or represented transcripts that could not be sufficiently verified, 145 genes were defined as the final biomarker cohort. Broad class analyses revealed that all six included classes (viral, bacterial, malaria, TB, KD, inflammatory) could be accurately distinguished in one-versus-one and one-versus-all analyses. Test set prediction results revealed that ML models can reliably predict most diagnostic classes, albeit with prediction performance being a function of training sample size. However, broad-scale class classification was reliable independent of training sample size, which highlights the future
6 minutes ago LINCOLN, Neb. (KLKN) — Local first responders are putting together a blood drive in honor of a fallen hero. Saturday marked three years since Lincoln Police Investigator Mario Herrera was shot while serving a warrant. He died 12 days later. But starting this Monday, you can give back in his honor. During those final 12 days of his life, officials say Herrera received countless amounts of blood transfusions, keeping him alive longer than anticipated. That’s why Lincoln Police and Lincoln Fire and Rescue are banding together for the “12 Days of Hope” blood drive. According to the American Red Cross, just one blood donation can save more than one life. If you’d like to donate, head to the Public Safety Center at 6601 Pine Lake Road from 9 a.m. to 2 p.m. Tags: 12 days of hope, 12 Days of Hope Blood Drive, American Red Cross, blood transfusion, Investigator Mario Herrera, Lincoln Fire & Rescue, Lincoln Fire and Rescue, Lincoln Police Department, Lincoln Police Investigator Mario Herrera, Mario Herrera., Public Safety Center
Mon, 28 Aug 2023 16:10:32 GMT (1693239032163) 6c1a9239626623b12804f7b5400cf5752fcbc847 a98b9a68b0d53dec453755579bc8ceb9717067d6 News Weather Features Sports Game Center Watch Now 74 Tue 84 Wed 76 by WICS Mon, August 28th 2023, 4:07 PM UTC Blood Drive Being Held in Springfield (WICS) Loading …
LOADINGERROR LOADING Florida state Rep. Angie Nixon (D) slammed the state’s governor, Ron DeSantis (R), in emotional remarks after a white man shot and killed three Black people in what officials described as a “racially motivated” attack in Jacksonville on Saturday. “Look, at the end of the day, the governor has blood on his hands,” Nixon, who represents a district that includes the site of the deadly Dollar General store shooting, told MSNBC on Sunday. Advertisement “He has had an attack, an all-out attack on the Black community with his anti-woke policies, which we know very well was nothing more than a dog whistle to get folks up and riled up in the way in which it just happened yesterday. As I listened to him for the first time with that statement, my blood is literally boiling,” Nixon said. The lawmaker criticized DeSantis, who has condemned the attack, after he said “targeting people due to their race has no place in the state of Florida” at a press conference on Sunday. DeSantis has come under fire for backing efforts to loosen gun restrictions, gone after what he describes as “woke” policies, and supported controversial standards for teaching Black history in his state. Nixon noted that she and other Black lawmakers have “repeatedly” warned the GOP presidential candidate about his rhetoric. Advertisement “This is absurd, it’s ridiculous. He is one of the causes to this. This is an agenda that he has been pushing since he has gotten into office,” said Nixon, who referred to the governor’s “monkey this up” remark when he ran against 2018 Democratic opponent Andrew Gillum, who is Black. “We have Republican leadership across this state who are doing everything to continually attack Black lives. They are doing everything to erase Black history. They are feeding our children propaganda. All that does is lead to the devaluation of Black lives,” she added. Nixon, who appeared alongside the governor as he was booed at a Jacksonville vigil on Sunday, wrote in a post on X (formerly called Twitter) that DeSantis “needs to apologize for his part” in the attack. “Gov. DeSantis and the Republican Party of Florida are doing nothing but hurting us. And I am angry. I will not continue to sit idly by,” Nixon said in an emotional message. You can watch more of Nixon’s remarks on MSNBC in the clip below. Maybe you don’t know who Florida state Rep Angie Nixon is, but you will now. 🔥🔥🔥 If you care about what life is like in Florida under Gov Ron DeSantis, I urge you to listen to ALL of this. You will feel it in your bones. Thank you, @AngieNixon #Jacksonville pic.twitter.com/mIFpfS0roh — Christopher Webb (@cwebbonline) August 27, 2023 Advertisement <div class="js-react-hydrator" data-component-name="RelatedArticles" data-component-id="1482" data-component-props="{"index":16,"contentListType":"relatedArticles","blockTitle":"Related…","articlesList":[{"id":"64ec09c5e4b05b73949db94b","editionId":"us","headline":"Ron DeSantis Booed At Vigil For Victims Of Jacksonville Shooting","url":"https://www.huffpost.com/entry/ron-desantis-booed-jacksonville_n_64ec09c5e4b05b73949db94b","dek":"The Florida governor did not get a warm welcome from those mourning the three people killed in Saturday's racist attack.","defaultImage":{"type":"hector","url":"https://img.huffingtonpost.com/asset/64ec0f462200003200f11918.jpeg","queryParams":{"cache":"nTipXd2Hlw"},"width":7880,"height":5253,"credit":"via Associated Press","ops":""},"section":{"Id":"5576fe88e4b00a64381c1325","title":"Politics","url":"politics"},"lastPublished":"2023-08-28T15:28:46Z"},{"id":"64ebbcb3e4b0d17252144ca7","editionId":"us","headline":"Sheriff Provides The First Details Of How A White Man Fatally Shot 3 Black People At A Florida Store","url":"https://www.huffpost.com/entry/ryan-palmeter-racist-shooting-jacksonville-florida_n_64ebbcb3e4b0d17252144ca7","dek":"Ryan Palmeter used an AR-15 semi-automatic rifle and a Glock handgun in the shooting, Sheriff T.K. Waters said during a press conference.","defaultImage":{"type":"hector","url":"https://img.huffingtonpost.com/asset/64ebbdb42700003a00fdb399.jpeg","queryParams":{},"width":2275,"height":1279,"credit":"- via Getty Images","ops":""},"section":{"Id":"59073c30e4b02655f83ea404","title":"U.S. News","url":"us-news"},"lastPublished":"2023-08-27T21:19:45Z"},{"id":"64eac5bde4b0a48e7f77edca","editionId":"us","headline":"Justin Jones Slams 'Asinine Governor' Ron DeSantis Following Deadly Jacksonville Shooting","url":"https://www.huffpost.com/entry/tennessee-democrat-justin-jones-jacksonville-shooting_n_64eac5bde4b0a48e7f77edca","dek":"The Tennessee state lawmaker went after politicians' "thoughts and prayers" in the wake of a Florida shooting that a sheriff described as "racially motivated."","defaultImage":{"type":"hector","url":"https://img.huffingtonpost.com/asset/64eae2692200001e008b137a.jpg","queryParams":{"cache":"PtpsacYRMi"},"width":960,"height":540,"credit":"AP Photo/George Walker IV | AP Photo/Jacquelyn Martin","ops":""},"section":{"Id":"5576fe88e4b00a64381c1325","title":"Politics","url":"politics"},"lastPublished":"2023-08-27T13:19:04Z"}],"showArticlesPics":true,"specialLayout":"","flags":[],"fullBleed":false,"options":{"theme":"news","device":"desktop","editionInfo":{"id":"us","name":"U.S.","link":"https://www.huffpost.com","locale":"en_US"},"slideshowAd":{"scriptTags":[],"otherHtml":""},"slideshowEndCard":{"scriptTags":[],"otherHtml":""},"isMapi":false,"isAmp":false,"isVideoEntry":false,"isEntry":true,"isMt":false,"entryId":"64ec4d03e4b0e32801d5e91e","entryPermalink":"https://www.huffpost.com/entry/angie-nixon-ron-desantis-jacksonville-shooting_n_64ec4d03e4b0e32801d5e91e","entryTagsList":"gun-violence,ron-desantis,shooting,msnbc,jacksonville-florida,@us_huffpost_now","sectionSlug":"politics","deptSlug":"politics-news","sectionRedirectUrl":null,"subcategories":"us-news,media","isWide":false,"headerOverride":null,"noVideoAds":false,"disableFloat":false,"isNative":false,"commercialVideo":{"provider":"custom","site_and_category":"us.politics","package":null},"isHighline":false,"vidibleConfigValues":{"cid":"60afc111dcf87c2cd2f5d8bf","overrides":{"front_page_top_videos":{"desktop":"60b64354b171b7444beaff4d","mobileweb":"60b64354b171b7444beaff4d"},"top_media":{"desktop":"60b8e6bdc5449357a7ada147","mobile":"60b8e701c5449357a7ada2ee","iphone":"60b8e643cdd90620331bb1f6","ipad":"60b8e643cdd90620331bb1f6","androidphone":"60b8e699c5449357a7ada04c","androidtablet":"60b8e699c5449357a7ada04c"},"anthology":{"desktop":"60b8e616cdd90620331bb0ba","mobile":"60b8e671c5449357a7ad9f66","iphone":"60b8e643cdd90620331bb1f6","ipad":"60b8e643cdd90620331bb1f6","androidphone":"60b8e699c5449357a7ada04c","androidtablet":"60b8e699c5449357a7ada04c"},"content":{"desktop":"60b8e616cdd90620331bb0ba","mobile":"60b8e671c5449357a7ad9f66","iphone":"60b8e643cdd90620331bb1f6","ipad":"60b8e643cdd90620331bb1f6","androidphone":"60b8e699c5449357a7ada04c","androidtablet":"60b8e699c5449357a7ada04c"}},"playerUpdates":{"5668ae6ee4b0b5e26955d6a6":"60d2472d9340d7032ad7e443","56aa41bae4b091744c0440d8":"60e869dc7c5f3b17b6741b81","5841b2b5cc52c716ec6e5a7f":"60b8e355cdd90620331ba185","58b5e2b8d85a10302feee895":"60b64316b171b7444beafdb2","58b74698f78ced31417819ae":"60b8e5bec5449357a7ad9b52","58b74ccecebcea57e2c3a3d1":"60b8e5eac5449357a7ad9ca5","58cff690d85a100b9992bc39":"60b8e616cdd90620331bb0ba","58cffb3fb6d9b972a49a3c9d":"60b8e643cdd90620331bb1f6","58cffdd74d96935d7d6ec180":"60b8e671c5449357a7ad9f66","58d03a84f78ced6518eb2fa7":"60b643c82e76be41f112735c","592edf20e0fa177b0c26f7fd":"60b8e699c5449357a7ada04c","5b35266b158f855373e28256":"60b64354b171b7444beaff4d","5c116f29f79c4171d82b7c2a":"60b64440b171b7444beb040b","5c1170fc600c9a697bf0c6b9":"60b646102e76be41f1127ffc","5c47791afa1b317df8ae0c4f":"60b8e6bdc5449357a7ada147","5c477987a6b48b35f164773d":"60b8e701c5449357a7ada2ee","5c4779ee943c3c2a64f28371":"60b8e747cdd90620331bb861","5c477a26fcd67b26879bc7c2":"60b8e788c5449357a7ada67b","5d8921a78c3ae845f366c9b6":"60ae7be5f3a7c13a30417ff9","58b98b00ba82aa39a6534321":"60d0de7c9340d7032ad1146c","58b9d14cb6d9b96c9ec32af3":"60d0dec19340d7032ad115a0","58cff8eccebcea42931e0436":"60d0e005b627221e9d819d44","592edf5de0fa177b0c26f95b":"60d0e38fb627221e9d81adcf","58cff72fd85a100b9992c112":"60d0e447b627221e9d81b0da","56b4d34fe4b022697697c400":"60d2472d9340d7032ad7e443","60b8e4c0c5449357a7ad957d":"60e869dc7c5f3b17b6741b81"}},"connatixConfigValues":{"defaultPlayer":"ff7fdddc-5441-4253-abc4-f12a33fad58b","clickToPlayPlayer":"d014396e-b366-4c17-aeac-3ce906fa3fd0","videoPagePlayer":"f010447b-d244-4111-a314-7b4542ae4145","verticalPlayer":"e58cb05a-0bc8-4210-9108-fea82726c065"},"customAmpComponents":[],"ampAssetsUrl":"https://amp.assets.huffpost.com","videoTraits":null,"positionInUnitCounts":{"buzz_head":{"count":0},"buzz_body":{"count":0},"buzz_bottom":{"count":0}},"positionInSubUnitCounts":{"article_body":{"count":12},"blog_summary":{"count":0},"before_you_go_slideshow":{"count":0}},"connatixCountsHelper":{"count":1},"buzzfeedTracking":{"context_page_id":"64ec4d03e4b0e32801d5e91e","context_page_type":"buzz","destination":"huffpost","mode":"desktop","page_edition":"en-us"},"tags":[{"name":"Gun Violence","slug":"gun-violence","links":{"relativeLink":"topic/gun-violence","permalink":"https://www.huffpost.com/topic/gun-violence","mobileWebLink":"https://www.huffpost.com/topic/gun-violence"},"department":{"name":"Latest News","slug":"politics-news"},"section":{"title":"Crime","slug":"crime"},"topic":{"title":"Gun Violence","slug":"gun-violence","overridesSectionLabel":false},"url":"https://www.huffpost.com/news/topic/gun-violence"},{"name":"Ron DeSantis","slug":"ron-desantis","links":{"relativeLink":"topic/ron-desantis","permalink":"https://www.huffpost.com/topic/ron-desantis","mobileWebLink":"https://www.huffpost.com/topic/ron-desantis"},"department":{"name":"Latest News","slug":"politics-news"},"section":{"title":"Politics","slug":"politics"},"topic":{"title":"Ron DeSantis","slug":"ron-desantis","overridesSectionLabel":false},"url":"https://www.huffpost.com/news/topic/ron-desantis"},{"name":" shooting","slug":"shooting","links":{"relativeLink":"topic/shooting","permalink":"https://www.huffpost.com/topic/shooting","mobileWebLink":"https://www.huffpost.com/topic/shooting"},"relegenceSubjectId":6377432,"department":{"name":"Latest News","slug":"politics-news"},"section":{"title":"Crime","slug":"crime"},"topic":{"title":"Shooting","slug":"shooting","overridesSectionLabel":false},"url":"https://www.huffpost.com/news/topic/shooting"},{"name":"MSNBC","slug":"msnbc","links":{"relativeLink":"topic/msnbc","permalink":"https://www.huffpost.com/topic/msnbc","mobileWebLink":"https://www.huffpost.com/topic/msnbc"},"department":{"name":"Latest News","slug":"politics-news"},"section":{"title":"Media","slug":"media"},"topic":{"title":"MSNBC","slug":"msnbc","overridesSectionLabel":false},"url":"https://www.huffpost.com/news/topic/msnbc"},{"name":"Jacksonville, Florida","slug":"jacksonville-florida","links":{"relativeLink":"topic/jacksonville-florida","permalink":"https://www.huffpost.com/topic/jacksonville-florida","mobileWebLink":"https://www.huffpost.com/topic/jacksonville-florida"},"url":"https://www.huffpost.com/topic/jacksonville-florida"}],"isLiveblogLive":null,"cetUnit":"buzz_body","bodyAds":[" rnrn HPGam.cmd.push(function(){rnttreturn HPGam.render(“inline-1”, “entry_paragraph_1″, false);rn });rnrn”,” rnrn HPGam.cmd.push(function(){rnttreturn HPGam.render(“inline-2”, “entry_paragraph_3″, false);rn });rnrn”,” rnrn HPGam.cmd.push(function(){rnttreturn HPGam.render(“inline-infinite”, “repeating_dynamic_display”, false);rn });rnrn”],”adCount”:0}}”> Related Gun ViolenceRon DeSantis shootingMSNBCJacksonville, Florida Ron DeSantis Booed At Vigil For Victims Of Jacksonville Shooting Sheriff Provides The First Details Of How A White Man Fatally Shot 3 Black People At A Florida Store Justin Jones Slams ‘Asinine Governor’ Ron DeSantis Following Deadly Jacksonville Shooting
Low blood pressure, or hypotension, is characterized by a blood pressure reading lower than 90 millimeters of mercury (mm Hg) for systolic pressure (the top number) or 60 mm Hg for diastolic pressure (the bottom number). While what constitutes low blood pressure can vary among individuals, it is essential to understand the causes, symptoms, diagnosis, and potential complications associated with hypotension. This comprehensive guide delves into the various aspects of low blood pressure, providing an extensive exploration of its types, symptoms, causes, treatment, risk factors, complications, diagnosis, lifestyle modifications, and more, ensuring that you have a thorough understanding of this medical condition. Types of Low Blood Pressure Low blood pressure manifests in various forms, each with unique causes and characteristics: 1. Orthostatic Hypotension (Postural Hypotension): This type of low blood pressure results in a sudden drop in blood pressure when transitioning from a sitting or lying position to standing. Causes include dehydration, prolonged bed rest, pregnancy, specific medical conditions, and certain medications. It is particularly common among older adults. 2. Postprandial Hypotension: Postprandial hypotension occurs approximately 1 to 2 hours after eating and predominantly affects older adults, especially those with high blood pressure or autonomic nervous system disorders like Parkinson’s disease. Managing this condition can involve consuming smaller, low-carbohydrate meals, increasing water intake, and avoiding alcohol. 3. Neurally Mediated Hypotension: This type involves a drop in blood pressure after standing for extended periods and mainly affects young adults and children. It often stems from a miscommunication between the heart and the brain. 4. Multiple System Atrophy with Orthostatic Hypotension (Shy-Drager Syndrome): A rare disorder that impacts the nervous system’s control over involuntary functions like blood pressure, heart rate, breathing, and digestion. It is characterized by very high blood pressure when lying down. Symptoms of Low Blood Pressure Low blood pressure, or hypotension, can lead to various symptoms, including: In severe cases, hypotension can escalate to the point of causing shock, which manifests as: If you experience symptoms of extreme low blood pressure or shock, it is imperative to seek emergency medical assistance. However, it is essential to understand that most healthcare providers consider blood pressure as too low only if it leads to noticeable symptoms. Occasional minor dizziness or lightheadedness can be attributed to factors such as sun exposure or hot baths. A healthcare provider should assess your condition for a proper diagnosis. Causes of Low Blood Pressure Blood pressure is influenced by the amount of blood the heart pumps and the resistance to blood flow within the arteries. Blood pressure readings consist of two numbers: Ideal blood pressure, as defined by the American Heart Association, is usually below 120/80 mm Hg. Blood pressure can fluctuate throughout the day due to various factors, including body position, breathing, food and drink intake, medications, physical condition, stress, and the time of day. It is typically lowest during nighttime and rises sharply upon waking. Several medical conditions can lead to low blood pressure, including: 1. Pregnancy: Changes during pregnancy can cause rapid blood vessel expansion, resulting in decreased blood pressure. It is common in the first 24 weeks of pregnancy, with blood pressure typically returning to pre-pregnancy levels after childbirth. 2. Heart and Heart Valve Conditions: Conditions such as heart attacks, heart failure, heart valve disease, and bradycardia (an extremely low heart rate) can induce low blood pressure. 3. Hormone-Related Diseases (Endocrine Disorders): Disorders affecting the parathyroid or adrenal glands, such as Addison’s disease, may lead to decreased blood pressure. Low blood sugar (hypoglycemia) and, sometimes, diabetes can also lower blood pressure. 4. Dehydration: Insufficient water intake reduces blood volume in the body, causing a drop in blood pressure. Conditions like fever, vomiting, severe diarrhea, overuse of diuretics, and intense exercise can result in dehydration. 5. Blood Loss: Significant blood loss, whether from an injury or internal bleeding, leads to a decrease in blood volume, causing a severe drop in blood pressure. 6. Severe Infection (Septicemia): When an infection enters the bloodstream, it can result in a life-threatening drop in blood pressure, known as septic shock. 7. Severe Allergic Reaction (Anaphylaxis): This reaction often involves a sudden and dramatic decrease in blood pressure. 8. Lack of Nutrients in the Diet: Low levels of vitamin B-12, folate, and iron can hinder the body’s production of red blood cells, leading to anemia, which can, in turn, cause low blood pressure. In addition to medical conditions, certain medications can be responsible for low blood pressure. Some of these medications include water pills (diuretics), alpha blockers, beta blockers, drugs for Parkinson’s disease, specific antidepressants, and drugs for erectile dysfunction, particularly when used alongside heart medication containing nitroglycerin. Risk Factors for Low Blood Pressure Low blood pressure can affect anyone, but some factors may increase the risk of experiencing hypotension, including: 1. Age: Drops in blood pressure when standing or following meals are more common in adults over the age of 65. Neurally mediated hypotension primarily affects children and younger adults. 2. Medications: Certain medications, including some prescribed for blood pressure management, can elevate the risk of low blood pressure. 3. Specific Diseases: Conditions such as Parkinson’s disease, diabetes, and certain heart conditions may heighten the likelihood of experiencing low blood pressure. Complications of Low Blood Pressure Low blood pressure can lead to various complications, including dizziness, weakness, fainting, and injuries resulting from falls. In severe cases, extremely low blood pressure can diminish oxygen levels in the body, potentially causing damage to the heart and brain. This underlines the significance of understanding, diagnosing, and managing low blood pressure to mitigate its possible adverse outcomes. Diagnosis of Low Blood Pressure To diagnose low blood pressure or hypotension, a healthcare provider conducts a physical examination and inquires about your medical history. During the examination, blood pressure is measured. Additional Tests Additional tests may be conducted to determine the underlying cause of low blood pressure: 1. Blood Tests: Blood tests help in diagnosing conditions such as low blood sugar (hypoglycemia), high blood sugar (hyperglycemia or diabetes), or a low red
Thrombocytopenia is a multifaceted medical condition characterized by a lower than normal count of platelets in the blood. Platelets, also known as thrombocytes, are colorless blood cells that play a critical role in blood clotting by forming clots in response to blood vessel injuries. While this condition can manifest in various ways, it is essential to understand its causes, symptoms, diagnosis, and available treatment options. This comprehensive and detailed article aims to provide a thorough understanding of thrombocytopenia, extending well beyond one thousand words and ensuring it is free from plagiarism. By delving into the various causes of thrombocytopenia, such as autoimmune disorders, medications, viral infections, or bone marrow disorders, readers can gain insights into the complexity of this condition. The array of symptoms associated with thrombocytopenia, including easy bruising, prolonged bleeding, petechiae, and fatigue, underscores the importance of early detection and medical intervention. The diagnostic process, which typically involves blood tests, bone marrow examinations, and medical history assessments, will be explored in depth to shed light on how healthcare professionals identify and classify thrombocytopenia. Moreover, the article will elaborate on the numerous treatment options available, which may include medication, blood transfusions, or, in severe cases, splenectomy. With an extensive examination of these facets, this article endeavors to equip readers with the knowledge needed to navigate the complexities of thrombocytopenia and make informed decisions about their healthcare. Causes of Thrombocytopenia Thrombocytopenia is often defined by a platelet count of fewer than 150,000 per microliter of circulating blood. Given that platelets have a short lifespan of about 10 days, the body continually produces new platelets in the bone marrow. There are several potential causes of thrombocytopenia, which can be broadly classified into three categories: 1. Trapped Platelets: The spleen, a fist-sized organ located beneath the ribcage on the left side of the abdomen, is primarily responsible for fighting infections and filtering unwanted substances from the blood. An enlarged spleen, which can result from various underlying conditions, can sequester an excessive number of platelets, reducing the number of platelets in circulation. 2. Decreased Platelet Production: Platelets are produced in the bone marrow, and various factors can hinder their production. These factors include conditions such as leukemia and other cancers, some types of anemia, viral infections like hepatitis C or HIV, chemotherapy drugs, radiation therapy, and heavy alcohol consumption. 3. Increased Platelet Destruction: Some medical conditions lead to a heightened rate of platelet consumption or destruction, leading to a deficit of platelets in the bloodstream. Examples of such conditions include pregnancy-induced thrombocytopenia, immune thrombocytopenia, bacterial infections causing bacteremia, thrombotic thrombocytopenic purpura, and hemolytic uremic syndrome. Certain medications, like heparin, quinine, sulfa-containing antibiotics, and anticonvulsants, can also reduce platelet counts, either by confusing the immune system or other mechanisms. Symptoms of Thrombocytopenia The symptoms of thrombocytopenia can vary in severity and presentation, but common signs and symptoms may include: Complications of Thrombocytopenia In rare cases, thrombocytopenia can lead to severe complications, particularly when the platelet count falls below 10,000 per microliter. The most dangerous complication is internal bleeding, which can occur in various parts of the body, including the brain. Intracranial bleeding can be fatal and is considered a medical emergency. Diagnosis of Thrombocytopenia To diagnose thrombocytopenia, healthcare professionals rely on various diagnostic methods, which include: 1. Blood Test: A complete blood count (CBC) is performed to determine the number of blood cells, including platelets, in a sample of your blood. A platelet count below the normal range is indicative of thrombocytopenia. 2. Physical Examination: A comprehensive physical examination, combined with a detailed medical history, is essential. Physicians will look for signs of bleeding under the skin and may check for an enlarged spleen by palpation. Additionally, your healthcare provider will inquire about any recent illnesses and the medications or supplements you’ve been taking. Depending on the specific signs and symptoms, additional tests or procedures may be recommended to determine the underlying cause of thrombocytopenia. Treatment of Thrombocytopenia The treatment approach for thrombocytopenia depends on the underlying cause and the severity of the condition. People with mild thrombocytopenia may not require treatment. For those who do, the following treatment options may be considered: 1. Addressing Underlying Causes: If the thrombocytopenia is secondary to an underlying condition or medication, addressing the root cause can resolve the issue. For example, if the cause is heparin-induced thrombocytopenia, an alternative anticoagulant may be prescribed. 2. Blood or Platelet Transfusions: In cases where the platelet count is critically low, blood or platelet transfusions may be necessary to replace lost blood components. This is typically reserved for severe cases. 3. Medications: For individuals with thrombocytopenia related to immune system dysfunction, medications that can boost platelet production or suppress the immune response may be prescribed. Initial treatment often involves corticosteroids, and in more resistant cases, stronger immunosuppressive medications may be considered. 4. Surgery: When other treatments prove ineffective, surgical removal of the spleen (splenectomy) may be recommended to prevent the sequestration of platelets. This is a less common option and is reserved for specific cases. 5. Plasma Exchange: Thrombotic thrombocytopenic purpura, a rare and severe form of thrombocytopenia, may necessitate plasma exchange as a medical emergency intervention to restore platelet counts. In conclusion, thrombocytopenia is a complex medical condition characterized by a reduced platelet count, and it can have a wide range of causes and symptoms. Early diagnosis and appropriate treatment are vital in managing thrombocytopenia, and the chosen treatment approach depends on the underlying cause and the severity of the condition. It is essential to consult with a healthcare professional for proper evaluation, diagnosis, and treatment if you suspect you may have thrombocytopenia or are experiencing its symptoms.
Renal Artery Stenosis
Renal artery stenosis, a complex medical condition characterized by the narrowing of arteries supplying blood to the kidneys, demands a comprehensive understanding for effective management. At the heart of this condition is the impediment of oxygen-rich blood reaching the kidneys, vital organs responsible for filtering waste products and regulating fluid balance. The repercussions of reduced blood flow extend beyond localized damage to the kidneys, impacting blood pressure regulation throughout the entire circulatory system. The subtle nature of renal artery stenosis often conceals its presence until it reaches an advanced stage. Symptoms may be absent in the early phases, with the condition frequently discovered incidentally during unrelated medical testing. Noteworthy signs prompting investigation include the abrupt onset or unexplained worsening of high blood pressure. Additionally, the age of onset—whether before 30 or after 50—may raise suspicions. As the condition progresses, manifestations such as uncontrollable hypertension, a distinctive whooshing sound (bruit) during auscultation over the kidneys, elevated protein levels in urine, worsening kidney function during hypertension treatment, and fluid retention with resultant tissue swelling may become apparent. In severe cases, treatment-resistant heart failure may ensue, underscoring the critical need for early detection and intervention. Renal artery stenosis arises from two primary causes: atherosclerosis and fibromuscular dysplasia. Atherosclerosis, the accumulation of fats, cholesterol, and plaque in kidney arteries, is a widespread condition contributing to arterial narrowing. Fibromuscular dysplasia, on the other hand, involves abnormal growth of the arterial wall muscle, often beginning in childhood, leading to a bead-like appearance in arterial images. Notably, fibromuscular dysplasia predominantly affects women and may be congenital. Risk factors amplifying the likelihood of narrowed kidney arteries include aging, high blood pressure, high cholesterol, diabetes, obesity, smoking, a family history of early heart disease, and a sedentary lifestyle. The intricate interplay of these factors contributes to the multifaceted nature of renal artery stenosis, emphasizing the importance of personalized risk assessments. Complications stemming from renal artery stenosis encompass a spectrum of health issues. From the immediate threat of high blood pressure to the more profound consequences of kidney failure necessitating dialysis or transplantation, the impact can be pervasive. Fluid retention leading to swollen extremities and shortness of breath due to pulmonary edema represent additional complications, highlighting the systemic implications of this condition. Diagnosing renal artery stenosis involves a meticulous evaluation, starting with a physical exam that includes auscultation over the kidney areas. Blood and urine tests, assessing kidney function and hormone levels, provide valuable diagnostic insights. Advanced imaging techniques, such as Doppler ultrasound, CT scans, magnetic resonance angiography (MRA), and renal arteriography, play pivotal roles in confirming the diagnosis and determining the severity of arterial blockages. The therapeutic approach to renal artery stenosis encompasses lifestyle modifications, medication, and procedural interventions. Lifestyle changes, including salt restriction, a heart-healthy diet, weight management, regular physical activity, stress reduction, and moderation in alcohol consumption, form the foundation of non-invasive management. Medications play a pivotal role in the comprehensive treatment plan for renal artery stenosis, with a primary focus on optimizing blood pressure control. The pharmacological arsenal employed in managing this condition encompasses a variety of drug classes, each strategically chosen to address specific aspects of blood pressure regulation and overall cardiovascular health. Among these medications, angiotensin-converting enzyme (ACE) inhibitors stand out, working to dilate blood vessels and reduce blood volume, subsequently alleviating the strain on the renal arteries. In conjunction with ACE inhibitors, angiotensin II receptor blockers (ARBs) are often incorporated into the treatment regimen. ARBs target the same renin-angiotensin-aldosterone system, effectively blocking the actions of angiotensin II and contributing to vasodilation and reduced blood pressure. Diuretics, commonly referred to as water pills, play a crucial role in promoting the elimination of excess sodium and water from the body, ultimately aiding in blood pressure management. Beta blockers, another class of medications, exert their effects by either slowing the heart rate or dilating blood vessels, depending on the specific drug used. This dual action contributes to overall blood pressure control. In a similar vein, alpha-beta blockers combine the benefits of both alpha and beta receptor blockade, offering a multifaceted approach to regulating blood pressure and minimizing the strain on renal arteries. Calcium channel blockers, a diverse group of medications, work by preventing calcium from entering the heart and blood vessel walls, leading to relaxed blood vessels and improved blood flow. This class of drugs is particularly effective in managing blood pressure, and their inclusion in the treatment plan reflects the nuanced approach required for optimal outcomes in renal artery stenosis. It is important to note that the choice and combination of medications are tailored to the individual patient, considering factors such as the severity of renal artery stenosis, overall health, and potential side effects. Achieving an optimal balance in blood pressure control is a dynamic process that may require adjustments over time to ensure the most effective and well-tolerated pharmacological regimen. Moreover, ongoing research and advancements in pharmacotherapy contribute to the evolving landscape of treatment options. Clinical trials and studies exploring novel medications or refining existing drug protocols underscore the commitment of the medical community to continually enhance the care and outcomes for individuals affected by renal artery stenosis. For select individuals, procedural interventions become necessary. Renal angioplasty and stenting involve widening the narrowed artery and placing a stent to maintain blood vessel patency. Alternatively, renal artery bypass surgery may be considered, creating a substitute blood vessel to restore blood flow to the kidneys. These interventions are particularly pertinent for individuals who do not respond well to medications, cannot tolerate them, or exhibit signs of treatment-resistant heart failure. In conclusion, the intricate landscape of renal artery stenosis demands a holistic approach to care, recognizing the interconnectedness of various risk factors and their implications. From early detection through meticulous diagnostic evaluations to personalized treatment strategies encompassing lifestyle modifications, medications, and, when warranted, procedural interventions, the collaborative efforts of healthcare providers and patients are paramount. Emphasizing the multifaceted nature of this condition underscores the importance of ongoing research, medical advancements, and a commitment to holistic patient
Leukemia
Leukemia, a complex group of blood cancers, primarily affects the body’s blood-forming tissues, including the bone marrow and the lymphatic system. Diverse types of leukemia exist, some with a predilection for children, while others predominantly afflict adults. At the heart of leukemia is the disruption of white blood cells, essential infection fighters within the body. Under normal circumstances, white blood cells proliferate and divide in an orderly manner, efficiently serving the body’s needs. However, in leukemia patients, the bone marrow undergoes an abnormal production of white blood cells that fail to function correctly. The management of leukemia can be intricate and multifaceted, dependent on the specific type of leukemia and individual patient factors. Nevertheless, various strategies and resources are available to enhance the efficacy of treatment. Exploring Leukemia: From Signs to Symptoms The presentation of leukemia symptoms varies, contingent on the particular type of leukemia. Nevertheless, there are common signs and symptoms associated with this group of blood cancers: 1. Fever or Chills: Patients may experience recurring fevers or chills, indicative of the body’s response to abnormal white blood cells. 2. Persistent Fatigue and Weakness: Unrelenting fatigue and physical weakness are common manifestations. 3. Frequent or Severe Infections: A weakened immune system often results in recurrent or severe infections. 4. Unexplained Weight Loss: Weight loss can occur unintentionally and is often associated with certain types of leukemia. 5. Enlarged Lymph Nodes, Liver, or Spleen: Swelling of lymph nodes, liver, or spleen is a frequent occurrence, leading to discomfort and concern. 6. Easy Bleeding or Bruising: Leukemia can cause issues with clotting, resulting in easy bleeding and bruising. 7. Recurrent Nosebleeds: Patients may experience nosebleeds on a recurrent basis. 8. Petechiae: Small red spots on the skin, known as petechiae, may manifest. 9. Excessive Sweating, Particularly at Night: Night sweats are a common occurrence in some cases. 10. Bone Pain or Tenderness: Patients may experience discomfort in the bones. When any of these symptoms persist, individuals should seek prompt medical evaluation and diagnosis. It is essential to note that leukemia symptoms are often nonspecific and vague, which may lead to overlooking early signs due to their resemblance to flu-like symptoms and common illnesses. Sometimes, leukemia is serendipitously discovered during routine blood tests conducted for unrelated conditions. Delving into the Causes of Leukemia Despite extensive research, the precise etiology of leukemia remains enigmatic. This condition appears to arise from a complex interplay of genetic and environmental factors. Leukemia is believed to occur when certain blood cells undergo mutations in their genetic material or DNA. These genetic abnormalities instruct the cells to defy their regular growth and programmed death cycle. In leukemia, mutated cells persistently multiply, leading to an uncontrollable increase in blood cell production. Over time, these aberrant cells infiltrate the bone marrow, outcompeting healthy white blood cells, red blood cells, and platelets. The ensuing scarcity of healthy blood cells gives rise to the hallmark signs and symptoms of leukemia. The classification of leukemia involves considering the speed of progression and the type of cells affected. Leukemia is categorized based on two primary factors: 1. Speed of Progression: 2. Type of Cells Affected: The Spectrum of Leukemia Types Leukemia is a diverse spectrum of diseases with distinct characteristics. The major types of leukemia include: 1. Acute Lymphocytic Leukemia (ALL): This is the most prevalent leukemia type among young children and can also occur in adults. 2. Acute Myelogenous Leukemia (AML): AML is a common leukemia type, affecting both children and adults. It is the most common form of acute leukemia among adults. 3. Chronic Lymphocytic Leukemia (CLL): CLL, the most common chronic leukemia in adults, often has an indolent course, with many patients not requiring immediate treatment. 4. Chronic Myelogenous Leukemia (CML): CML primarily affects adults and may remain asymptomatic for an extended period before the leukemia cells begin to proliferate rapidly. 5. Other Types: Leukemia encompasses a range of rare types, including hairy cell leukemia, myelodysplastic syndromes, and myeloproliferative disorders. Risk Factors and Leukemia Several factors may heighten an individual’s risk of developing specific types of leukemia: 1. Previous Cancer Treatment: People who have received certain chemotherapy and radiation therapy for prior cancer treatments face an elevated risk of developing particular leukemia types. 2. Genetic Disorders: Genetic anomalies are implicated in the genesis of leukemia. Certain genetic conditions, such as Down syndrome, are associated with an augmented risk of leukemia. 3. Exposure to Chemicals: Contact with certain chemicals, such as benzene, which is found in gasoline and used in the chemical industry, has been linked to a heightened risk of specific leukemia variants. 4. Smoking: Smoking cigarettes has been identified as a risk factor for acute myelogenous leukemia. 5. Family History: Individuals with a family history of leukemia may face an increased risk of the disease. It is important to note that having known risk factors does not guarantee the development of leukemia, and conversely, many individuals diagnosed with leukemia have no identifiable risk factors. Leukemia’s multifactorial nature underscores the complexity of its onset. Diagnosing Leukemia Leukemia can be identified through a series of diagnostic steps, often initiated by a clinical evaluation of the patient’s health. The diagnostic process typically involves the following: 1. Physical Examination: Physicians examine patients for physical indicators of leukemia, which may include pale skin due to anemia, swollen lymph nodes, and an enlarged liver and spleen. 2. Blood Tests: A blood sample is analyzed to determine the presence of abnormal levels of red or white blood cells or platelets, which can be indicative of leukemia. It may also reveal the presence of leukemia cells; however, not all types of leukemia lead to the circulation of leukemia cells in the blood. In certain cases, leukemia cells may remain confined to the bone marrow. 3. Bone Marrow Test: A bone marrow sample may be collected via a minimally invasive procedure from the patient’s hipbone. This sample is sent to a laboratory where it is scrutinized for the presence of leukemia cells. Specialized tests on leukemia cells may